MFA
ABBV icon

Mayflower Financial Advisors’s AbbVie ABBV Stock Holding History

Mayflower Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.6M Buy
101,672
+81,369
+401% +$17.5M 2.21% 5
2026
Q1 		$4.42M Buy
20,303
+1,127
+6% +$250K 0.54% 49
2025
Q4 		$4.38M Buy
19,176
+78
+0.4% +$17.8K 0.53% 49
2025
Q3 		$4.42M Buy
19,098
+3,414
+22% +$695K 0.55% 47
2025
Q2 		$2.91M Sell
15,684
-51
-0.3% -$9.48K 0.41% 61
2025
Q1 		$3.3M Buy
15,735
+83
+0.5% +$16.1K 0.5% 50
2024
Q4 		$2.78M Sell
15,652
-342
-2% -$62.9K 0.42% 58
2024
Q3 		$3.16M Sell
15,994
-224
-1% -$41.8K 0.48% 53
2024
Q2 		$2.78M Sell
16,218
-34
-0.2% -$5.63K 0.46% 56
2024
Q1 		$2.96M Sell
16,252
-78,439
-83% -$13.5M 0.49% 51
2023
Q4 		$14.7M Sell
94,691
-489
-0.5% -$71.3K 2.03% 9
2023
Q3 		$14.2M Sell
95,180
-1,960
-2% -$288K 2.12% 8
2023
Q2 		$13.1M Buy
97,140
+683
+0.7% +$100K 1.7% 13
2023
Q1 		$15.4M Buy
96,457
+283
+0.3% +$43.3K 2.02% 9
2022
Q4 		$15.5M Buy
96,174
+1,099
+1% +$169K 2.16% 9
2022
Q3 		$12.8M Buy
95,075
+292
+0.3% +$41.9K 2.06% 11
2022
Q2 		$14.5M Sell
94,783
-769
-0.8% -$118K 2.22% 9
2022
Q1 		$15.5M Buy
95,552
+279
+0.3% +$40.5K 2.08% 11
2021
Q4 		$12.9M Buy
95,273
+1,623
+2% +$192K 1.71% 13
2021
Q3 		$10.1M Buy
93,650
+172
+0.2% +$19.7K 1.36% 16
2021
Q2 		$10.5M Sell
93,478
-50
-0.1% -$5.63K 1.45% 18
2021
Q1 		$10.1M Buy
93,528
+339
+0.4% +$36.3K 1.5% 18
2020
Q4 		$9.98M Buy
+93,189
New +$8.96M 1.72% 16

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Mayflower Financial Advisors's ABBV Position: Q2 2026 in Review

Mayflower Financial Advisors increased its AbbVie (ABBV) stake by 401% in Q2 2026, buying an estimated $17.5M and bringing the position to 101,672 shares worth $25.6M. The position accounts for 2.21% of the portfolio, ranked #5.

Mayflower Financial Advisors first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mayflower Financial Advisors held 101,672 shares of AbbVie worth $25.6M as of Q2 2026.
  • Mayflower Financial Advisors bought 81,369 AbbVie shares in Q2 2026, an estimated $17.5M.
  • AbbVie made up 2.21% of Mayflower Financial Advisors's portfolio in Q2 2026, its #5 holding.
  • Mayflower Financial Advisors first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mayflower Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.